Selecting Minimally Invasive Surgical Treatments for Benign Prostatic Hyperplasia: A Clinical Consultation Guide.

IF 4.8 2区医学 Q1 UROLOGY & NEPHROLOGY

European urology focus Pub Date : 2025-05-09 DOI:10.1016/j.euf.2025.04.025

Peter Ka-Fung Chiu, Brian W H Siu, Cosimo De Nunzio

引用次数: 0

Abstract

Optimal patient selection on the basis of prostate size, presence of a median lobe, and patient preferences is key to success for various minimally invasive surgical treatments for benign prostatic hyperplasia (BPH), including Rezūm, UroLift, a temporary implantable nitinol device, prostate artery embolization, and Optilume BPH balloon dilatation.

查看原文本刊更多论文

选择微创手术治疗良性前列腺增生：临床咨询指南。

根据前列腺大小、正中叶是否存在和患者偏好来选择最佳患者是各种微创手术治疗良性前列腺增生（BPH）成功的关键，包括Rezūm、UroLift（一种临时植入式镍钛诺装置）、前列腺动脉栓塞和Optilume BPH球囊扩张。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

European urology focus Medicine-Urology

CiteScore

10.40

自引率

3.70%

发文量

274

审稿时长

23 days

期刊介绍： European Urology Focus is a new sister journal to European Urology and an official publication of the European Association of Urology (EAU). EU Focus will publish original articles, opinion piece editorials and topical reviews on a wide range of urological issues such as oncology, functional urology, reconstructive urology, laparoscopy, robotic surgery, endourology, female urology, andrology, paediatric urology and sexual medicine. The editorial team welcome basic and translational research articles in the field of urological diseases. Authors may be solicited by the Editor directly. All submitted manuscripts will be peer-reviewed by a panel of experts before being considered for publication.